CN104830815B - A kind of method that α phenylpyruvic acids are efficiently produced using resting cell - Google Patents
A kind of method that α phenylpyruvic acids are efficiently produced using resting cell Download PDFInfo
- Publication number
- CN104830815B CN104830815B CN201510295252.6A CN201510295252A CN104830815B CN 104830815 B CN104830815 B CN 104830815B CN 201510295252 A CN201510295252 A CN 201510295252A CN 104830815 B CN104830815 B CN 104830815B
- Authority
- CN
- China
- Prior art keywords
- whole
- amino acid
- acid deaminase
- ppa
- cell catalyst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种采用全细胞转化高效生产α‑苯丙酮酸的方法,属于发酵工程领域。本发明对L‑氨基酸脱氨酶进行了改造,获得活性提高的L‑氨基酸脱氨酶突变体。以含有L‑氨基酸脱氨酶突变体的重组菌全组细胞转化L‑苯丙氨酸生产PPA,L‑苯丙氨酸生产PPA的转化率显著提高。本发明建立的全细胞转化体系,解决了化学法合成PPA的步骤繁琐、得率低、污染环境等问题及酶法转化生产PPA的转化率低的问题,实现了无污染、高产率、一步法生产PPA,为后续工业化生产奠定了一定的理论基础。The invention discloses a method for efficiently producing α-phenylpyruvate by transforming whole cells, and belongs to the field of fermentation engineering. The invention transforms the L-amino acid deaminase to obtain the L-amino acid deaminase mutant with improved activity. The transformation rate of L-phenylalanine to produce PPA is significantly improved by transforming L-phenylalanine with the whole group of cells of the recombinant bacteria containing the L-amino acid deaminase mutant. The whole-cell transformation system established by the present invention solves the problems of cumbersome steps, low yield, and polluted environment for chemically synthesizing PPA and the low conversion rate of PPA produced by enzymatic transformation, and realizes pollution-free, high-yield, one-step method The production of PPA has laid a certain theoretical foundation for the subsequent industrial production.
Description
技术领域technical field
本发明涉及一种采用全细胞转化高效生产α-苯丙酮酸的方法,属于发酵工程领域。The invention relates to a method for efficiently producing α-phenylpyruvate by transforming whole cells, belonging to the field of fermentation engineering.
背景技术Background technique
α-苯丙酮酸(PPA)有很多应用,可用来合成抗肿瘤药物的杂环化合物,可作为抗氧化剂及促进伤口愈合。是合成D-苯丙氨酸的原材料,D-苯丙氨酸是手性药物中间体。PPA还可用于制备苯乳酸,苯乳酸可作为抗菌物质。传统PPA生产采用化学法,化学法的主要缺点是缺乏选择性,采用有毒的氰化物及金属铜,产率低,且污染环境。酶和全细胞生物催化剂越来越多的用于工业化生产。α-Phenylpyruvate (PPA) has many applications. It can be used to synthesize heterocyclic compounds of antineoplastic drugs, as an antioxidant and to promote wound healing. It is the raw material for the synthesis of D-phenylalanine, which is a chiral drug intermediate. PPA can also be used to prepare phenyllactic acid, which can be used as an antibacterial substance. Traditional PPA production adopts chemical method. The main disadvantage of chemical method is the lack of selectivity, the use of toxic cyanide and metal copper, low yield, and environmental pollution. Enzymes and whole-cell biocatalysts are increasingly used in industrial production.
L-氨基酸脱氨酶(EC1.4.3.2)催化L-氨基酸氧化脱氨基,生成相应α-酮酸和氨,多为黄素蛋白,二聚体结构。Proteus mirabilis KCTC2566有两种L-氨基酸脱氨酶,一种具有广泛的底物特异性,能够催化脂肪族和芳香族L-氨基酸,尤其对L-苯丙氨酸具有较高催化活性;另一种具有底物限制性,只对碱性氨基酸具有催化活性,尤其是L-组氨酸。L-amino acid deaminase (EC1.4.3.2) catalyzes the oxidative deamination of L-amino acids to generate corresponding α-keto acids and ammonia, mostly flavoproteins with a dimer structure. Proteus mirabilis KCTC2566 has two L-amino acid deaminases, one has broad substrate specificity and can catalyze aliphatic and aromatic L-amino acids, especially for L-phenylalanine with high catalytic activity; the other The species is substrate-limited and only catalytically active towards basic amino acids, especially L-histidine.
全细胞转化相比分离酶具有许多优势:易制备,成本低;更稳定,使用方便;无污染,副产物少。之前的研究中我们已经成功构建了大肠杆菌全细胞催化剂,并对大肠杆菌进行改造,敲除了降解PPA的三种氨基酸脱氨酶,转化率39%。Whole-cell transformation has many advantages over isolate enzymes: easy preparation and low cost; more stable and convenient to use; no pollution and less by-products. In previous studies, we have successfully constructed a whole-cell catalyst of E. coli, and transformed E. coli to knock out the three amino acid deaminases that degrade PPA, with a conversion rate of 39%.
发明内容Contents of the invention
本发明要解决的第一个技术问题是提供一种L-氨基酸脱氨酶突变体,是以核苷酸序列如SEQ ID NO.1所示的基因编码的酶作为亲本改造得到,所述L-氨基酸脱氨酶突变体是D165G/S179L/F263V/L336V或D165K/F263M/L336M或D165K或F263M或L336M。The first technical problem to be solved by the present invention is to provide a mutant of L-amino acid deaminase, which is obtained by transforming the enzyme encoded by the gene whose nucleotide sequence is shown in SEQ ID NO.1 as a parent, said L-amino acid deaminase - the amino acid deaminase mutant is D165G/S179L/F263V/L336V or D165K/F263M/L336M or D165K or F263M or L336M.
所述突变体可以通过易错PCR和/或定点突变获得。Said mutants can be obtained by error-prone PCR and/or site-directed mutagenesis.
本发明要解决的第二个技术问题是提供含有所述L-氨基酸脱氨酶突变体的全细胞催化剂,是将编码所述L-氨基酸脱氨酶突变体的基因转化大肠杆菌得到重组菌,所得重组菌可用于高效转化L-苯丙氨酸生产PPA。The second technical problem to be solved by the present invention is to provide a whole-cell catalyst containing the L-amino acid deaminase mutant, which is to transform the gene encoding the L-amino acid deaminase mutant into Escherichia coli to obtain a recombinant bacterium, The obtained recombinant bacteria can be used to efficiently transform L-phenylalanine to produce PPA.
在本发明的一种实施方式中,所述大肠杆菌是E.coli BL21(DE3)。In one embodiment of the present invention, the Escherichia coli is E. coli BL21(DE3).
本发明要解决的第三个技术问题是提供应用所述全细胞催化剂转化生产α-苯丙酮酸的方法,将L-苯丙氨酸10-12g/L、全细胞催化剂1.2-1.5g/L,在20mM Tris-HCl(pH8.0)中,于36-37℃、200-220rpm转化6h。The third technical problem to be solved by the present invention is to provide a method for converting and producing α-phenylpyruvate using the whole-cell catalyst, by mixing L-phenylalanine 10-12g/L and whole-cell catalyst 1.2-1.5g/L , in 20mM Tris-HCl (pH8.0), at 36-37°C, 200-220rpm for 6h.
所述全细胞催化剂是湿菌体。The whole cell catalyst is wet bacteria.
在本发明的一种实施方式中,所述全细胞催化剂的获得,是将含有L-氨基酸脱氨酶突变体的重组大肠杆菌按1-2%接种量接到1.8L发酵培养基中,搅拌转速、通气量和温度分别为400rpm、1.0vvm和28℃,当OD600达到0.6-0.8,加入0.4mM IPTG诱导L-氨基酸脱氨酶表达。诱导5-7h后,8,000rpm低温离心10-15min,收集菌体,用20mM Tris-HCl(pH8.0)缓冲液洗两遍菌体即得。In one embodiment of the present invention, the whole cell catalyst is obtained by connecting recombinant Escherichia coli containing L-amino acid deaminase mutants into 1.8L fermentation medium according to 1-2% inoculum size, stirring The rotational speed, air flow and temperature were 400rpm, 1.0vvm and 28°C, respectively. When the OD 600 reached 0.6-0.8, 0.4mM IPTG was added to induce the expression of L-amino acid deaminase. After induction for 5-7 hours, centrifuge at 8,000 rpm for 10-15 minutes at low temperature, collect the bacteria, and wash the bacteria twice with 20 mM Tris-HCl (pH8.0) buffer solution.
在本发明的一种实施方式中,发酵培养基:蛋白胨12g,酵母提取物24g,甘油4mL。各组分溶解后高压灭菌。冷却到60℃,再加100mL灭菌的17mmol/L KH2PO4和72mmol/LK2HPO4的溶液(2.31g的KH2PO4和12.54g的K2HPO4溶于水中,终体积为100mL,高压灭菌)。In one embodiment of the present invention, fermentation medium: peptone 12g, yeast extract 24g, glycerin 4mL. The components are dissolved and autoclaved. Cool to 60°C, add 100mL sterilized solution of 17mmol/L KH 2 PO 4 and 72mmol/L K 2 HPO 4 (dissolve 2.31g of KH 2 PO 4 and 12.54g of K 2 HPO 4 in water, the final volume is 100 mL, autoclaved).
在本发明的一种实施方式中,全细胞转化体系为:L-苯丙氨酸10g/L,全细胞催化剂1.2g/L,反应在20mM Tris-HCl(pH8.0)中进行,37℃,200rpm转化6h。In one embodiment of the present invention, the whole cell transformation system is: L-phenylalanine 10g/L, whole cell catalyst 1.2g/L, the reaction is carried out in 20mM Tris-HCl (pH8.0), 37 ℃ , 200rpm conversion 6h.
本发明的有益效果:本发明成功实现了L-氨基酸脱氨酶的改造,提高了利用大肠杆菌重组细胞转化L-苯丙氨酸生产PPA的转化率。含有L-氨基酸脱氨酶突变体D165G/S179L/F263V/L336V的重组菌全细胞转化L-苯丙氨酸生产PPA的转化率为81%。含有L-氨基酸脱氨酶突变体D165K/F263M/L336M的重组菌全细胞转化L-苯丙氨酸生产PPA的转化率为100%。本发明建立的全细胞转化体系,解决了化学法合成PPA的步骤繁琐、得率低、污染环境等问题及酶法转化生产PPA的转化率低的问题,实现了无污染、高产率、一步法生产PPA,为后续工业化生产奠定了一定的理论基础。Beneficial effects of the present invention: the present invention successfully realizes the transformation of L-amino acid deaminase, and improves the conversion rate of producing PPA by transforming L-phenylalanine with Escherichia coli recombinant cells. The conversion rate of whole cells of recombinant bacteria containing L-amino acid deaminase mutant D165G/S179L/F263V/L336V to L-phenylalanine to produce PPA is 81%. The conversion rate of whole cells of recombinant bacteria containing L-amino acid deaminase mutant D165K/F263M/L336M to transform L-phenylalanine to produce PPA is 100%. The whole-cell transformation system established by the present invention solves the problems of cumbersome steps, low yield, and polluted environment for chemically synthesizing PPA and the low conversion rate of PPA produced by enzymatic transformation, and realizes pollution-free, high-yield, one-step method The production of PPA has laid a certain theoretical foundation for the subsequent industrial production.
具体实施方式detailed description
材料与方法Materials and Methods
种子培养基:蛋白胨1g,酵母粉0.5g,NaCl1g,自来水定容至100mL。Seed medium: peptone 1g, yeast powder 0.5g, NaCl 1g, tap water to 100mL.
发酵培养基:蛋白胨12g,酵母提取物24g,甘油4mL。各组分溶解后高压灭菌。冷却到60℃,再加100mL灭菌的17mmol/L KH2PO4和72mmol/L K2HPO4的溶液。Fermentation medium: peptone 12g, yeast extract 24g, glycerol 4mL. The components are dissolved and autoclaved. After cooling to 60°C, add 100 mL of a sterilized solution of 17 mmol/L KH 2 PO 4 and 72 mmol/L K 2 HPO 4 .
PPA含量测定:将转化体系进行离心,取上清100μL,加入3mL三氯化铁,分光光度计测定640nm的吸光度。Determination of PPA content: Centrifuge the transformation system, take 100 μL of supernatant, add 3 mL of ferric chloride, and measure the absorbance at 640 nm with a spectrophotometer.
实施例1易错PCR对L-氨基酸脱氨酶进行改造Example 1 Error-prone PCR transforms L-amino acid deaminase
以P.mirabilisKCTC2566的基因组为模板,克隆得到编码L-氨基酸脱氨酶的基因pma,连接载体pET-20b(+),以所得重组质粒pET-pma为模板,Mutazyme II DNA polymerase低保真酶扩增pma基因。PCR产物纯化、酶切后,与载体pET-20b(+)连接,构建重组质粒,转化大肠杆菌BL21构建突变体文库。挑取氨苄抗性平板上生长的单菌落接种到LB,在96孔板中37℃震荡过夜培养,接种到另一块96孔板的TB培养基中,IPTG诱导5h,测定PPA产量。初筛后,PPA产量高的菌株摇瓶发酵复筛,进一步测试底物转化率,(底物转化率=转化为PPA的底物浓度/初始底物浓度*100%)。转化率高的菌株,提取质粒,作为下一轮易错PCR或定点饱和突变的模板。Using the genome of P. mirabilisKCTC2566 as a template, the gene pma encoding L-amino acid deaminase was cloned, connected to the vector pET-20b(+), and the obtained recombinant plasmid pET-pma was used as a template, and Mutazyme II DNA polymerase low-fidelity enzyme amplification increase pma gene. After the PCR product was purified and digested, it was ligated with the vector pET-20b(+) to construct a recombinant plasmid, and transformed into Escherichia coli BL21 to construct a mutant library. Pick a single colony grown on the ampicillin-resistant plate and inoculate it into LB, culture it overnight in a 96-well plate with shaking at 37°C, inoculate it into another 96-well plate in TB medium, induce it with IPTG for 5 hours, and measure the PPA production. After the primary screening, the strains with high PPA production were re-screened by shake flask fermentation, and the substrate conversion rate was further tested, (substrate conversion rate=substrate concentration converted into PPA/initial substrate concentration*100%). For the strains with high transformation rate, extract the plasmid and use it as a template for the next round of error-prone PCR or site-directed saturation mutation.
实施例2定点突变对L-氨基酸脱氨酶进行改造Example 2 Site-directed mutagenesis transforms L-amino acid deaminase
对实施例1得到的转化率高的突变体的突变位点逐个进行定点饱和突变。以实施例1突变后的重组质粒为模板,Prime-STAR HS DNA polymerase高保真酶及设计的突变引物一步法扩增,DpnI限制性内切酶消化模板DNA,然后磷酸化,连接为全质粒,转化大肠杆菌BL21。Site-directed saturation mutation was performed on the mutation sites of the mutants with high conversion rate obtained in Example 1 one by one. Using the mutated recombinant plasmid in Example 1 as a template, Prime-STAR HS DNA polymerase high-fidelity enzyme and designed mutation primers were amplified in one step, and the template DNA was digested with DpnI restriction endonuclease, then phosphorylated, and connected into a complete plasmid. Escherichia coli BL21 was transformed.
两轮改造后,得到的单突变体中,PPA产量较高的突变体为:D165K,F263M,L336M。将这几个突变位点组合在一起,构建复合突变体D165K/F263M/L336M。含野生型L-氨基酸脱氨酶及各突变体的重组菌全细胞转化PPA的转化率如表1所示。After two rounds of transformation, among the single mutants obtained, the mutants with higher PPA production were: D165K, F263M, and L336M. These several mutation sites were combined to construct the compound mutant D165K/F263M/L336M. Table 1 shows the conversion rates of whole cells transformed with recombinant bacteria containing wild-type L-amino acid deaminase and various mutants into PPA.
表1Table 1
实施例3全细胞催化剂的制备及全细胞转化过程Embodiment 3 preparation of whole cell catalyst and whole cell transformation process
实施例1和实施例2的重组大肠杆菌BL21接种种子培养基(氯霉素10mg/L),37℃,200rpm过夜培养。发酵在3LNBS发酵罐中进行,1%接种量到1.8L发酵培养基中,搅拌转速、通气量和温度分别为400rpm、1.0vvm和28℃,当OD600达到0.6,加入0.4mM IPTG诱导L-氨基酸脱氨酶表达。诱导5h后,8,000rpm低温离心10min,收集菌体,用20mM Tris-HCl(pH8.0)缓冲液洗两遍菌体。全细胞转化体系为:L-苯丙氨酸10g/L,全细胞催化剂1.2g/L,反应在20mMTris-HCl(pH8.0)中进行,37℃,200rpm转化6h。The recombinant Escherichia coli BL21 of Example 1 and Example 2 were inoculated with seed medium (chloramphenicol 10 mg/L), and cultivated overnight at 37° C. and 200 rpm. Fermentation was carried out in a 3L NBS fermenter, 1% inoculum was added to 1.8L fermentation medium, the stirring speed, ventilation volume and temperature were 400rpm, 1.0vvm and 28°C, respectively. When the OD600 reached 0.6, 0.4mM IPTG was added to induce L- Amino acid deaminase expression. After 5 hours of induction, centrifuge at 8,000 rpm for 10 minutes at low temperature, collect the bacterial cells, and wash the bacterial cells twice with 20 mM Tris-HCl (pH 8.0) buffer solution. The whole cell transformation system is: L-phenylalanine 10g/L, whole cell catalyst 1.2g/L, the reaction is carried out in 20mM Tris-HCl (pH8.0), 37°C, 200rpm transformation for 6h.
含D165G/S179L/F263V/L336V(SEQIDNO.2)突变体的重组菌,全细胞转化L-苯丙氨酸生产PPA的转化率为81%。含D165K/F263M/L336M(SEQ ID NO.3)突变体的重组菌,全细胞转化L-苯丙氨酸生产PPA的转化率为100%。For the recombinant bacteria containing the D165G/S179L/F263V/L336V (SEQ ID NO.2) mutant, the transformation rate of the whole cell into L-phenylalanine to produce PPA is 81%. For the recombinant bacteria containing the D165K/F263M/L336M (SEQ ID NO.3) mutant, the transformation rate of whole cells into L-phenylalanine to produce PPA is 100%.
虽然本发明已以较佳实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可做各种的改动与修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed above with preferred embodiments, it is not intended to limit the present invention. Any person familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore The scope of protection of the present invention should be defined by the claims.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510295252.6A CN104830815B (en) | 2015-06-02 | 2015-06-02 | A kind of method that α phenylpyruvic acids are efficiently produced using resting cell |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510295252.6A CN104830815B (en) | 2015-06-02 | 2015-06-02 | A kind of method that α phenylpyruvic acids are efficiently produced using resting cell |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104830815A CN104830815A (en) | 2015-08-12 |
| CN104830815B true CN104830815B (en) | 2018-02-23 |
Family
ID=53809015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510295252.6A Active CN104830815B (en) | 2015-06-02 | 2015-06-02 | A kind of method that α phenylpyruvic acids are efficiently produced using resting cell |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104830815B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105039434B (en) * | 2015-09-08 | 2018-02-27 | 浙江工业大学 | A kind of method of microorganism conversion synthesis phenyllactic acid |
| CN105647846B (en) * | 2016-03-05 | 2019-04-23 | 江南大学 | A kind of recombinant bacteria with improved efficiency of transformation and production of α-phenylpyruvate |
| CN106497905A (en) * | 2016-12-14 | 2017-03-15 | 江南大学 | The mutant of the PD in one plant of anabena source |
| CN107083353A (en) * | 2017-05-27 | 2017-08-22 | 江南大学 | A kind of method that use resting cell produces Aspartame |
| CN107904222B (en) * | 2017-11-30 | 2019-10-08 | 江南大学 | A kind of l-amino acid deaminase mutant and its construction method that thermal stability improves |
| CN108277190A (en) * | 2018-01-18 | 2018-07-13 | 江南大学 | A kind of method of resting cell phenylalanine production phenyllactic acid |
| CN109097383A (en) * | 2018-08-10 | 2018-12-28 | 浙江正硕生物科技有限公司 | A kind of method of high flux screening l-amino acid deamination enzyme mutant recombinant bacterial strain |
| CN109652391A (en) * | 2019-01-29 | 2019-04-19 | 中国科学院华南植物园 | A kind of L-phenylalanine TRANSAMINASE POLYPEPTIDES and its application |
| CN112831453B (en) * | 2019-11-25 | 2022-09-27 | 江南大学 | Escherichia coli having amino acid oxidase incorporated therein |
| CN116656638B (en) * | 2023-05-26 | 2025-06-24 | 浙大宁波理工学院 | Membrane-combined L-amino acid deaminase mutant and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0132118B1 (en) * | 1983-07-13 | 1989-10-11 | Smithkline Beckman Corporation | Antibiotics produced by kibdelosporangium aridum shearer gen. nov., sp. nov. atcc 39323 |
| CN102212567A (en) * | 2010-04-02 | 2011-10-12 | 中国科学院上海生命科学研究院湖州工业生物技术中心 | Method for producing L-2-aminobutyric acid |
| CN103642743A (en) * | 2013-09-02 | 2014-03-19 | 江南大学 | Method for producing alpha-phenylpyruvic acid efficiently through whole cell transformation |
| CN103789247A (en) * | 2014-02-14 | 2014-05-14 | 江南大学 | Method for producing alpha-ketoisocaproate by whole-cell transformation |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004511249A (en) * | 2000-10-17 | 2004-04-15 | ピーシービーユー サービシイズ, インコーポレイテッド | Production of α-hydroxycarboxylic acids using combined enzyme systems |
-
2015
- 2015-06-02 CN CN201510295252.6A patent/CN104830815B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0132118B1 (en) * | 1983-07-13 | 1989-10-11 | Smithkline Beckman Corporation | Antibiotics produced by kibdelosporangium aridum shearer gen. nov., sp. nov. atcc 39323 |
| CN102212567A (en) * | 2010-04-02 | 2011-10-12 | 中国科学院上海生命科学研究院湖州工业生物技术中心 | Method for producing L-2-aminobutyric acid |
| CN103642743A (en) * | 2013-09-02 | 2014-03-19 | 江南大学 | Method for producing alpha-phenylpyruvic acid efficiently through whole cell transformation |
| CN103789247A (en) * | 2014-02-14 | 2014-05-14 | 江南大学 | Method for producing alpha-ketoisocaproate by whole-cell transformation |
Non-Patent Citations (5)
| Title |
|---|
| Expression and characterization of a second L-amino acid deaminase isolated from Proteus mirabilis in Escherichia coli;Jin-Oh Baek等;《Journal of Basic Microbiology》;20111231;第51卷;第129-135页 * |
| Proteus mirabilis Amino Acid Deaminase:Cloning,Nucleotide Sequence, and Characterization of aad;GEORGE MASSAD等;《JOURNAL OF BACTERIOLOGY》;19951031;第177卷(第20期);第5878-5883页 * |
| Purification and characterization of an L-amino acid deaminase used to prepare unnatural amino acids;David P.Pantaleone等;《Journal of Molecular Catalysis B: Enzymatic》;20011231;第11卷;第795-803页 * |
| 全细胞生物转化L-苯丙氨酸生产α-苯丙酮;侯颖等;《第九届中国酶工程学术研讨会论文摘要集》;20131130;第216页 * |
| 奇异变形杆菌TJ-1产絮凝剂的培养基优化研究;杨阿明等;《环境科学学报》;20071231;第27卷(第12期);第1988-1993页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104830815A (en) | 2015-08-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104830815B (en) | A kind of method that α phenylpyruvic acids are efficiently produced using resting cell | |
| CN104531629B (en) | A kind of yclodextrin glycosyltransferase mutant of raising AA 2G conversion ratios | |
| CN103911400B (en) | A kind of method adopting resting cell to produce α-ketoglutaric acid | |
| CN107686850B (en) | Method for producing alpha-ketoglutaric acid by converting co-expression recombinant strain | |
| CN110628741B (en) | Maltooligosyl trehalose synthase mutant and application thereof | |
| JP2024515083A (en) | Enzyme composition for preparing β-nicotinamide mononucleotide and its application | |
| CN105062997A (en) | L-asparaginase mutant with improved enzyme activity and construction method thereof | |
| CN107794273A (en) | A kind of three gene co-expressing carriers of synthesis DL alanine and application | |
| CN104130967B (en) | One plant of coexpression L lactic dehydrogenase and the Escherichia coli of hydrogenlyase and its construction method and application | |
| CN114672525B (en) | Biosynthesis method and application of N-acetyl-5-methoxy tryptamine | |
| CN104531637A (en) | Beta-glucosaccharase, beta-glucosaccharase mutant and application | |
| CN105647846B (en) | A kind of recombinant bacteria with improved efficiency of transformation and production of α-phenylpyruvate | |
| CN107227286B (en) | A genetically engineered bacterium with high production of succinic acid and its construction method and application | |
| CN104862264B (en) | A kind of recombinant bacterium for converting production α-phenylpyruvic acid efficiency and improving | |
| CN103937842B (en) | Method for increasing yield of alpha-oxoglutarate produced through whole-cell transformation | |
| CN105087457B (en) | A kind of method that RBS optimizations improve α ketoisocaproate yield | |
| CN105062998A (en) | Genetic-engineering L-asparaginase amidohydrolase modified through site-specific mutagenesis | |
| CN115851685B (en) | A nitrilase and its application in the synthesis of 3-hydroxy-3-methylbutyric acid | |
| US9963684B2 (en) | Formaldehyde dehydrogenase and method for preparing formaldehyde using same | |
| CN105177026A (en) | Cis-3-hydroxy-L-proline hydroxylase modified gene and application thereof | |
| CN108060145B (en) | 2, 3-butanediol dehydrogenase mutant with improved enzyme activity and construction method thereof | |
| CN107119003A (en) | A kind of utilization glucan synthesizes recombinant bacterium and its construction method and the application of 3 hydracrylic acids | |
| CN109517778B (en) | A kind of method of Bacillus subtilis whole cell transforming phenylalanine to produce phenyllactic acid | |
| CN115873816B (en) | A transaminase mutant for synthesizing sitagliptin | |
| CN110904086B (en) | Tryptophanase mutant and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |